2minutemedicine.com3h
Sex differences in mortality among patients with lupus nephritis
Males with lupus nephritis had higher all-cause mortality and proportion of infection-related death compared to females.
thecardiologyadvisor.com11h
Lupus Does Not Affect Post-Acute Myocardial Infarction Outcomes
There are no significant differences in outcomes post-AMI in patients with systemic lupus erythematosus vs the general population.
News Medical on MSN6d
Unique immune response in lupus paves the way for new treatments
Immune cells called monocytes produce a key inflammatory protein called interleukin-1 beta (IL-1β) through an unconventional ...
Artist who tackles lupus in her paintings seeks a kidney donor
Three different versions of Alexandria Wingate appear in a trio of purple paintings the Baltimorean started while a fine art ...
GlobalData on MSN4d
Kezar Life Sciences discontinues lupus nephritis programme after fatalities
Clinical stage biopharma Kezar Life Sciences is discontinuing its lupus nephritis (LN) clinical programme following the death ...
BioSpace15d
Kezar’s Lupus Trial Paused After Four Patient Deaths
The clinical hold doesn’t cover its drug’s Investigational New Drug application for autoimmune hepatitis, for which the Phase ...
Pharmabiz5d
Cullinan Therapeutics gets US FDA clearance to proceed phase 1 trial of CLN-978 in patients with moderate to severe systemic lupus erythematosus
Cambridge, Massachusetts Thursday, October 17, 2024, 17:00 Hrs [IST] ...
Benzinga.com15d
FDA Put Brakes On Penny Stock Kezar Life Sciences' Mid-Stage Study For Lead Development Candidate After Patient Deaths
Lupus nephritis is a type of kidney disease caused by systemic lupus erythematosus link (SLE or lupus). Lupus is an ...
Alumis' Investigational Lead Candidate Supports Superior Profile Than Bristol Myers' Commercialized Drug, Analyst Sees 170% Stock Upside
HC Wainwright has initiated coverage on Alumis Inc. (NASDAQ:ALMS), a clinical-stage biopharmaceutical company developing oral ...
Hosted on MSN28d
Biogen-UCB's lupus drug meets main goal of late-stage trial
The unexpected success, if replicated in a second late-stage study ... tested in patients with the most common form of lupus, systemic lupus erythematosus, where the patient's immune system ...